Cell IDx offers custom biomarker multiplex assay development services to biotechnology, CRO, and
pharmaceutical companies. Whether you are a pharmaceutical company developing a new drug/CDx
offering, a CRO needing assays to look at 4, 8, or 12 biomarkers in situ in tissue sections,
or an antibody company wanting to offer your own multiplex immunofluorescence panels to your
customer, we can help enable your technology.
Please contact us to discuss your needs with a call or email, or complete the form below.